Immunology of leprosy and diagnostic challenges
- PMID: 25432814
- DOI: 10.1016/j.clindermatol.2014.07.005
Immunology of leprosy and diagnostic challenges
Abstract
Leprosy, caused by noncultivable Mycobacterium leprae (ML), has varied manifestations, which are associated with the host immune responses. The dermal involvement is accompanied by peripheral nerve damage, which leads to sensory motor loss and deformities. Both innate and acquired immune responses are involved. The main cell to be compromised is the CD4 + T helper cell, which shows antigen specific unresponsiveness to only ML and not to other common antigens in the bacilliferous generalized lepromatous form of the disease. In contrast, the paucibacillary localized tuberculoid form shows appropriate T cell functions and poor antibody response. The dichotomy between T cell functions and antibodies are discussed against the current information on cytokines, Th subsets, and regulatory T cells. During lepromatous reactions, there is a temporary, heightened T cell immunity, even in lepromatous subjects. The dermal lesions confirm many features observed with peripheral blood mononuclear cells and give additional information on local immune responses. Nerve damage involves both immune and nonimmune mechanisms. Leprosy is a model disease for understanding host immune responses to intracellular bacilli. There are challenges in diagnosing early leprosy. In spite of intensive efforts by many groups, consensus on a universal test suitable for endemic areas is awaited.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.Nature. 1986 Jul 31-Aug 6;322(6078):462-4. doi: 10.1038/322462a0. Nature. 1986. PMID: 2426597
-
T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.Eur J Immunol. 1989 Apr;19(4):707-13. doi: 10.1002/eji.1830190421. Eur J Immunol. 1989. PMID: 2659369
-
M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.J Immunol. 1986 Jun 1;136(11):4255-63. J Immunol. 1986. PMID: 2422278
-
HLA and leprosy in the pre and postgenomic eras.Hum Immunol. 2006 Jun;67(6):439-45. doi: 10.1016/j.humimm.2006.03.009. Epub 2006 Apr 3. Hum Immunol. 2006. PMID: 16728267 Review.
-
The immunobiology of leprosy.Int Rev Exp Pathol. 1986;28:45-78. Int Rev Exp Pathol. 1986. PMID: 3516911 Review.
Cited by
-
Functional Impairment of Skin Appendages Due to Peripheral Nerve Involvement by Mycobacterium leprae.Open Forum Infect Dis. 2020 Sep 12;7(10):ofaa419. doi: 10.1093/ofid/ofaa419. eCollection 2020 Oct. Open Forum Infect Dis. 2020. PMID: 33094119 Free PMC article.
-
T-cell regulation in Erythema Nodosum Leprosum.PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0006001. doi: 10.1371/journal.pntd.0006001. eCollection 2017 Oct. PLoS Negl Trop Dis. 2017. PMID: 28991896 Free PMC article.
-
Serum Levels of Ficolin-3 and Mannose-Binding Lectin in Patients with Leprosy and Their Family Contacts in a Hyperendemic Region in Northeastern Brazil.Trop Med Infect Dis. 2022 May 10;7(5):71. doi: 10.3390/tropicalmed7050071. Trop Med Infect Dis. 2022. PMID: 35622698 Free PMC article.
-
The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.Front Immunol. 2018 Feb 9;9:189. doi: 10.3389/fimmu.2018.00189. eCollection 2018. Front Immunol. 2018. PMID: 29479352 Free PMC article.
-
Diagnostic value of neutrophil-to-lymphocyte ratio in patients with leprosy reactions.Heliyon. 2020 Feb 13;6(2):e03369. doi: 10.1016/j.heliyon.2020.e03369. eCollection 2020 Feb. Heliyon. 2020. PMID: 32083213 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials